PTJ
BHVN

Paul Tudor Jones’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Paul Tudor Jones’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-300,000
Closed -$45.4M – 3054
2022
Q3 		$45.4M Buy
+300,000
New +$44.5M 0.98% 6

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Paul Tudor Jones's BHVN Position: Q4 2022 in Review

Paul Tudor Jones sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 475,004 shares — an estimated $71.8M sold.

Paul Tudor Jones first reported a position in BHVN in Q2 2019 and held it in 10 quarters. The position peaked at $71.8M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Paul Tudor Jones reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Paul Tudor Jones sold 475,004 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $71.8M.
  • Paul Tudor Jones first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 10 quarters.
  • Paul Tudor Jones's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $71.8M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.